Oral Corticosteroid Selection and Management for Discharge After Asthma Exacerbation

Recommended Oral Steroid Options (NAEPP)

• The National Asthma Education and Prevention Program (NAEPP) endorses prednisone, prednisolone, and methylprednisolone as the three oral corticosteroids for acute asthma exacerbations, all using the same dosing schema. 1

Dosing and Transition from Intravenous to Oral Therapy

• For discharge, transition to oral prednisone or prednisolone at 40–80 mg daily for adults (given in one or two divided doses) or 1–2 mg/kg/day for children (maximum 60 mg/day); these agents are guideline‑recommended and have efficacy equivalent to intravenous steroids when gastrointestinal absorption is intact. 1

Course Duration and Tapering

• Prescribe a total oral corticosteroid course of 5–10 days for most patients; a taper is generally unnecessary. 1
• Hospitalized exacerbations typically require a 3–10‑day course; courses shorter than 1 week do not require tapering. 1
• Even for courses up to 10 days, tapering is probably unnecessary, especially when the patient continues inhaled corticosteroid therapy. 1

Effect of Viral Co‑infection (e.g., RSV)

• The presence of respiratory syncytial virus (RSV) co‑infection does not alter steroid selection or dosing; systemic corticosteroids remain the standard treatment for asthma exacerbations regardless of viral trigger. 1

Practical Recommendations & Common Pitfalls (NAEPP)

• Switch to oral steroids promptly once the patient can tolerate oral intake; continued intravenous steroids provide no added benefit. 1
• Avoid unnecessarily long taper regimens, as they do not improve outcomes and increase overall steroid exposure. 1
• Do not use higher-than‑recommended steroid doses; higher doses have not demonstrated additional clinical advantage in severe asthma exacerbations. 1